Power point
ksutar
imberlycrawford14unit1assighment.doc.docxLogi model
Kimberly Crawford
Logic Model
Program Aim: to reduce rates of vaccine-preventable diseases among adolescents
|
Critical Issues/gaps
|
Input |
Activities |
Outcomes |
||
|
|
|
|
Short-term Outcomes |
Middle-term Outcomes |
Long-term Outcomes |
|
Limited access to professionals for vaccination Feedback from the vaccination sectors and partnership. Limited access to funds to facilitate the vaccination process.
|
Updated immunization schedule Funds for the purchasing service and vaccine provision. Forming partnership with the education sector.
|
Information developed and distributed via high school newsletter. Development of parents’ information kits and consent forms designed and distributed. Operational protocol management Frequent meetings held with stakeholders in the education sector. Purchasing of vaccination and administration equipment. Authorized nurse immunizer employed
|
Increase knowledge and understanding of vaccine-preventable infections and the benefit of being a vaccine. |
Improved monitoring f vaccine safety Increased vaccination rate among the youth. |
Improved health in the community. Reduced rate of vaccine infection |
Reducing the rates of vaccine-preventable diseases among adolescents
Administering vaccination is among the most successful strategy and cost-efficient way of preventing the mortality and mobility caused by vaccine-preventable diseases. However, vaccine-preventable infections continue to be a major cause of early death among young adults and adolescents. Vaccinating girls before the onset of sexual activities with vaccination against Human Papillomavirus (HPV) can significantly reduce their risks of cervical cancer in their adult life (Nelson et al., 2018). Therefore, adolescents need to take the various vaccine, since their benefits are witnessed in their adult life. Many deaths due to vaccine-preventable diseases are due to the minimal vaccination coverage among the youth. Therefore, there is the need to conduct more public research with the intention of neutralizing the effect of such diseases (Banzhoff, 2017).
Useful immunization results to individuals acquiring a protective immunity against most targeted pathogens. When a sufficiently large number of youths are vaccinated, the herd immunity develops and prevent the spread of the infection within the population. At a young age, children and adolescents are vulnerable to different forms of vaccine-preventive infection due to their lower level of immunity. Extending vaccination throughout the life, especially during the adolescent stage is the best strategy for ensuring a healthy nation. Targeting the adolescent with important vaccines offer the major benefits: primary immunization with the new vaccine, boosting of waning immunity and catch-up on missed vaccination. Optimal vaccination rate can be achieved in adolescent since it covers various ages from 10 to 19 (Banzhoff, 2017).
How to implement the program to improve the overall health of the community
Implementing a program is the best way of making it relevant to the community. The implementation of reducing vaccine-preventive diseases can happen through the following stages. Each community health development program is unique hence there are no specific criteria for implementing them. A successful program identifies the presence of best practices and shapes them to meet the community needs. Resources for the implementation of the program are according to the plans goals, scope, and model. For a successful implementation of reducing vaccine-preventive diseases on the adolescent, the program may require resources like the staff, space, and transportation. Othe factors are the relationship with the community, recruitment of nurses, staff retention, and training the staff (Nelson et al., 2018).
References
Nelson, N. P., Yankey, D., Singleton, J. A., & Elam-Evans, L. D. (2018). Hepatitis A vaccination coverage among adolescents (13–17 years) in the United States, 2008–2016. Vaccine, 36(12), 1650-1659.
Banzhoff, A. (2017). Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States. Therapeutic advances in vaccines, 5(1), 3-14.
